Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11

1 Nov 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac electrophysiology and arrhythmias
Share to Cardiac Ischemia and Reperfusion
Share to Pancreatic function and diabetes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17982434
DOI: 10.1038/ncpneuro0640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11PMID 17982434Read ↗

Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.Semantic proximity Read ↗

Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.Semantic proximity Read ↗

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.Semantic proximity Read ↗

Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome).Semantic proximity Read ↗

Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.Semantic proximity Read ↗

Central/nervous system/neuromuscularchannelopathies.Semantic proximity Read ↗

Early transition to sulfonylurea therapy in infant with DEND syndrome due to F132L ABCC8 mutation.Semantic proximity Read ↗

Sulfonylurea for improving neurological features in neonatal diabetes: A systematic review and meta-analyses.Semantic proximity Read ↗

A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.Semantic proximity Read ↗

SCN9A Epileptic Encephalopathy Mutations Display a Gain-of-function Phenotype and Distinct Sensitivity to OxcarbazepineSemantic proximity Read ↗

Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.Semantic proximity Read ↗

The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.